ALOX15 and Alzheimer disease: The first direct evidence indicating that the 12-LOX metabolic pathway is altered in AD was demonstrated in post-mortem analysis by Pratico et al. [119], who showed an increase in 12/15-LOX protein level, in the frontal and temporal cortex.